Inmune Bio (INMB) Total Debt (2021 - 2024)
Historic Total Debt for Inmune Bio (INMB) over the last 4 years, with Q3 2024 value amounting to $5.0 million.
- Inmune Bio's Total Debt fell 5964.77% to $5.0 million in Q3 2024 from the same period last year, while for Sep 2024 it was $5.0 million, marking a year-over-year decrease of 5964.77%. This contributed to the annual value of $9.9 million for FY2023, which is 3249.64% down from last year.
- Inmune Bio's Total Debt amounted to $5.0 million in Q3 2024, which was down 5964.77% from $10.0 million recorded in Q2 2024.
- Inmune Bio's Total Debt's 5-year high stood at $15.0 million during Q1 2024, with a 5-year trough of $5.0 million in Q3 2024.
- For the 4-year period, Inmune Bio's Total Debt averaged around $13.1 million, with its median value being $14.5 million (2021).
- In the last 5 years, Inmune Bio's Total Debt soared by 172.26% in 2023 and then tumbled by 5964.77% in 2024.
- Over the past 4 years, Inmune Bio's Total Debt (Quarter) stood at $14.5 million in 2021, then rose by 1.65% to $14.7 million in 2022, then crashed by 32.5% to $9.9 million in 2023, then plummeted by 49.66% to $5.0 million in 2024.
- Its last three reported values are $5.0 million in Q3 2024, $10.0 million for Q2 2024, and $15.0 million during Q1 2024.